2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Pluhackova K et al. Extension of the LOPLS-AA Force Field for Alcohols, Esters, and Monoolein Bilayers and its Validation by Neutron Scattering Experiments. 2015 J Phys Chem B pmid:26537654
Wibroe PP et al. Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriers. 2015 Nanomedicine pmid:26348655
Rosa A et al. Monoolein-based cubosomes affect lipid profile in HeLa cells. 2015 Chem. Phys. Lipids pmid:26341749
Pham AC et al. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging. 2015 Drug Deliv Transl Res pmid:26328930
Gonçalves VSS et al. Supercritical fluid precipitation of ketoprofen in novel structured lipid carriers for enhanced mucosal delivery--a comparison with solid lipid particles. 2015 Int J Pharm pmid:26277371
Mohamed AI et al. In-vivo evaluation of clindamycin release from glyceryl monooleate-alginate microspheres by NIR spectroscopy. 2015 Int J Pharm pmid:26276253
Oliveira AC et al. Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells. 2015 Acta Biomater pmid:26225736
Sato H et al. Physicochemical stability study on cyclosporine A loaded dry-emulsion formulation with enhanced solubility. 2015 Chem. Pharm. Bull. pmid:25743195
Rachmawati H et al. Intraoral film containing insulin-phospholipid microemulsion: formulation and in vivo hypoglycemic activity study. 2015 AAPS PharmSciTech pmid:25511810
Barriga HM et al. Temperature and pressure tuneable swollen bicontinuous cubic phases approaching nature's length scales. 2015 Soft Matter pmid:25430049
Salvati Manni L et al. Phase behavior of a designed cyclopropyl analogue of monoolein: implications for low-temperature membrane protein crystallization. 2015 Angew. Chem. Int. Ed. Engl. pmid:25418121
Bhatt AB et al. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization. 2015 Curr Drug Deliv pmid:25176029
Silva JP et al. Structural dynamics and physicochemical properties of pDNA/DODAB:MO lipoplexes: effect of pH and anionic lipids in inverted non-lamellar phases versus lamellar phases. 2014 Biochim. Biophys. Acta pmid:24976292
Zhou Y et al. Biological artificial fluid-induced non-lamellar phases in glyceryl monooleate: the kinetics pathway and its digestive process by bile salts. 2014 Drug Dev Ind Pharm pmid:23350691
Madheswaran T et al. Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants. 2014 AAPS PharmSciTech pmid:24222268
Maselko J et al. Emergence of complex behavior in chemical cells: the system AlCl₃-NaOH. 2014 Langmuir pmid:24805150
Cohen-Avrahami M et al. HIV-TAT enhances the transdermal delivery of NSAID drugs from liquid crystalline mesophases. 2014 J Phys Chem B pmid:24798650
Kolev VL et al. Unit cell structure of water-filled monoolein into inverted hexagonal (H(II)) mesophase modeled by molecular dynamics. 2014 J Phys Chem B pmid:24787641
Ghattas N et al. Monoolein production by triglycerides hydrolysis using immobilized Rhizopus oryzae lipase. 2014 Int. J. Biol. Macromol. pmid:24755261
Oliveira AC et al. Dioctadecyldimethylammonium:monoolein nanocarriers for efficient in vitro gene silencing. 2014 ACS Appl Mater Interfaces pmid:24712543